NCRI's Clinical and Translational Radiotherapy Research Working Group (CTRad) is 10 this year!

CTRad is one of NCRI’s flagship initiatives and this year we are celebrating its ten year anniversary. Since 2009, CTRad has provided leadership in the national effort to enhance radiotherapy research and has transformed this environment to make the UK a leader in the global effort to improve outcomes for cancer patients through radiotherapy.

 

  • RaDCom

RaDCom

Working in partnership with industry and funders to progress preclinical radiotherapy-drug combinations

  • RTTQA group

RTTQA group

Advice and delivery of radiotherapy trial quality assurance

  • RADCAS

RADCAS

Trial development support: Radiotherapy protocol checklist, biomarker support network

CTRad is funded by the following Partners:

 CRUK  MRC 

        Prostate Cancer UK  breast cancer now logo